Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Cancer cell or component thereof
Reexamination Certificate
2006-08-29
2006-08-29
Huff, Sheela J. (Department: 1643)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Cancer cell or component thereof
C424S184100, C424S130100, C424S174100, C530S387100, C530S387700
Reexamination Certificate
active
07097846
ABSTRACT:
This invention provides the isolation and characterization of a tumor associated antigen which can be used for immunodiagnosis, immunoprognosis, and therapy of human cancer. The antigen is a protein molecule with a molecular weight of about 35 kD after reduction and separation by SDS-polyacrylamide gel electrophoresis. The antigen has been detected in serum of cancer patients.
REFERENCES:
patent: 4851510 (1989-07-01), Khan
Essell , J. NIH Res. 1995 7:46.
Spitler, Cancer Biotherapy, 1995, 10:1-3.
Boon, Adv. Can. Res. 1992 58:177-210.
Gupta Rishab K.
Morton Donald L.
Wong Jan H.
CancerVax Corporation
Huff Sheela J.
Wilson Sonsini Goodrich & Rosati
LandOfFree
35 kD tumor associated protein antigen: uses and methods of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 35 kD tumor associated protein antigen: uses and methods of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 35 kD tumor associated protein antigen: uses and methods of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3624610